These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19321494)

  • 1. Is lowering phosphate exposure the key to preventing arterial stiffening with age?
    Ferro CJ; Chue CD; Steeds RP; Townend JN
    Heart; 2009 Nov; 95(21):1770-2. PubMed ID: 19321494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arteriosclerosis and arterial calcifications in chronic kidney insufficiency].
    London GM
    Nephrol Ther; 2005 Dec; 1 Suppl 4():S351-4. PubMed ID: 17373207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Major impact of arteriosclerosis on cardiovascular morbidity and mortality].
    Gusbeth-Tatomir P; Covic A
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):11-5. PubMed ID: 16607820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial stiffness in chronic kidney disease: causes and consequences.
    Chue CD; Townend JN; Steeds RP; Ferro CJ
    Heart; 2010 Jun; 96(11):817-23. PubMed ID: 20406771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes and consequences of increased arterial stiffness in chronic kidney disease patients.
    Gusbeth-Tatomir P; Covic A
    Kidney Blood Press Res; 2007; 30(2):97-107. PubMed ID: 17374960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Republished paper: Arterial stiffness in chronic kidney disease: causes and consequences.
    Chue CD; Townend JN; Steeds RP; Ferro CJ
    Postgrad Med J; 2010 Sep; 86(1019):560-6. PubMed ID: 20841331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphate levels and cardiovascular disease in the general population.
    Foley RN
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1136-9. PubMed ID: 19423568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.
    Shioi A; Nishizawa Y
    J Ren Nutr; 2009 Jan; 19(1):78-81. PubMed ID: 19121777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate is a uremic toxin.
    Burke SK
    J Ren Nutr; 2008 Jan; 18(1):27-32. PubMed ID: 18089440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice.
    Westenfeld R; Schäfer C; Smeets R; Brandenburg VM; Floege J; Ketteler M; Jahnen-Dechent W
    Nephrol Dial Transplant; 2007 Jun; 22(6):1537-46. PubMed ID: 17389622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial calcification and stiffness in chronic kidney disease.
    Kerr PG; Guerin AP
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):683-7. PubMed ID: 17581230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular disease and atherosclerosis in uremia.
    London GM
    Nefrologia; 2005; 25 Suppl 2():91-5. PubMed ID: 16050410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular risk factors in chronic renal failure].
    López Gómez JM; Jofré R; Cases A
    Nefrologia; 2002; 22 Suppl 1():59-67. PubMed ID: 11987672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial structural and functional alterations in uraemia.
    Guérin AP; Marchais SJ; Metivier F; London GM
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():85-8. PubMed ID: 16281963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models--what they can tell us about vascular calcification in CKD.
    Massy ZA; Slama M; Tribouilloy C; Drüeke TB
    Semin Dial; 2007; 20(2):110-2. PubMed ID: 17374083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular changes in chronic renal failure--pathogenesis and therapy.
    Amann K; Tyralla K
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S62-72. PubMed ID: 12227729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients.
    Cupisti A; Aparicio M; Barsotti G
    Ren Fail; 2007; 29(5):529-34. PubMed ID: 17654313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease.
    Chung AW; Yang HH; Kim JM; Sigrist MK; Chum E; Gourlay WA; Levin A
    Circulation; 2009 Sep; 120(9):792-801. PubMed ID: 19687355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional cardiovascular consequences of vascular calcification.
    McIntyre CW
    Semin Dial; 2007; 20(2):122-8. PubMed ID: 17374085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular calcification in uremia: what is new and where are we going?
    Al-Aly Z
    Adv Chronic Kidney Dis; 2008 Oct; 15(4):413-9. PubMed ID: 18805387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.